MD102

News alerts, weekly reports and conference planners

Company:

MDBiolab

Drug class:

TGM2 inhibitor

‹

›

TGM2 overexpression	Renal Cell Carcinoma	TGM2 overexpression	Renal Cell Carcinoma	MD102 Sensitive: D – Preclinical MD102 Sensitive : D	MD102 Sensitive: D – Preclinical MD102 Sensitive : D
TGM2 overexpression	Gastric Cancer	TGM2 overexpression	Gastric Cancer	MD102 Sensitive: D – Preclinical MD102 Sensitive : D	MD102 Sensitive: D – Preclinical MD102 Sensitive : D
TGM2 overexpression	Triple Negative Breast Cancer	TGM2 overexpression	Triple Negative Breast Cancer	MD102 Sensitive: D – Preclinical MD102 Sensitive : D	MD102 Sensitive: D – Preclinical MD102 Sensitive : D

Associations
(3)